ConductScience.org, home

Paper39679804

Targeted Delivery of c(RGDfk)-Modified Liposomes to Bone Marrow Through In Vivo Hitchhiking Neutrophils for Multiple Myeloma Therapy.

Liu H and 7 others. Adv Sci (Weinh), 2025. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Targeted Delivery of c(RGDfk)-Modified Liposomes to Bone Marrow Through In Vivo Hitchhiking Neutrophils for Multiple Myeloma Therapy. Papers, record 39679804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39679804

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeted Delivery of c(RGDfk)-Modified Liposomes to Bone Marrow Through In Vivo Hitchhiking Neutrophils for Multiple Myeloma Therapy.
PubMed
Journal
Adv Sci (Weinh)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
2.79, provisional
iCite
Revised in PubMed
2025-05-18
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu HHuiwen
2Zhang BBo
3Chen HHongrui
4Wang HHonglan
5Qin XXifeng
6Sun CChunyan
7Pang ZZhiqinghttps://orcid.org/0000-0003-0228-904X
8Hu YYu

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Multiple MyelomaMajor topic
LiposomesMajor topic
NeutrophilsMajor topic
Bone MarrowMajor topic
OligopeptidesMajor topic
Drug Delivery SystemsMajor topic
Animals
Mice
Humans
Tumor Microenvironment

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82070228National Natural Science Foundation of ChinaPubMed
81773283National Natural Science Foundation of ChinaPubMed
2024SWBS009Research Grant of Key Laboratory of Molecular Biological Targeted Therapies of the Ministry of EducationPubMed

Source PubMed

Download CSV of grants

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135339668Recent advances of nanodrug delivery system in the treatment of hematologic malignancies.Semin Cancer Biol2022https://conductscience.org/library/papers/35339668PubMed
221057511Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria.Nat Immunol2010https://conductscience.org/library/papers/21057511PubMed
337199393The role of the host-Neutrophil biology.Periodontol 20002023https://conductscience.org/library/papers/37199393PubMed
431776467Extramedullary multiple myeloma.Leukemia2020https://conductscience.org/library/papers/31776467PubMed
527418644Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication.Blood2016https://conductscience.org/library/papers/27418644PubMed
635377708Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk.J Clin Oncol2022https://conductscience.org/library/papers/35377708PubMed
738486995Biomimetic "Gemini nanoimmunoregulators" orchestrated for boosted photoimmunotherapy by spatiotemporally modulating PD-L1 and tumor-associated macrophages.Acta Pharm Sin B2024https://conductscience.org/library/papers/38486995PubMed
834536449Cell-based therapeutics for the treatment of hematologic diseases inside the bone marrow.J Control Release2021https://conductscience.org/library/papers/34536449PubMed
925822788IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.Nature2015https://conductscience.org/library/papers/25822788PubMed
1018509199The role of the bone marrow in neutrophil clearance under homeostatic conditions in the mouse.FASEB J2008https://conductscience.org/library/papers/18509199PubMed
1136873164Reprogrammed siTNFα/neutrophil cytopharmaceuticals targeting inflamed joints for rheumatoid arthritis therapy.Acta Pharm Sin B2023https://conductscience.org/library/papers/36873164PubMed
1226707720Rutin Attenuates Carfilzomib-Induced Cardiotoxicity Through Inhibition of NF-κB, Hypertrophic Gene Expression and Oxidative Stress.Cardiovasc Toxicol2017https://conductscience.org/library/papers/26707720PubMed
1339679804Targeted Delivery of c(RGDfk)-Modified Liposomes to Bone Marrow Through In Vivo Hitchhiking Neutrophils for Multiple Myeloma Therapy.Adv Sci (Weinh)2025https://conductscience.org/library/papers/39679804PubMed
1427269947Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.J Clin Oncol2016https://conductscience.org/library/papers/27269947PubMed
1530662556Redox Dual-Responsive and O2‑Evolving Theranostic Nanosystem for Highly Selective Chemotherapy against Hypoxic Tumors.Theranostics2019https://conductscience.org/library/papers/30662556PubMed
1638438374Metabolic remodeling by the PD-L1 inhibitor BMS-202 significantly inhibits cell malignancy in human glioblastoma.Cell Death Dis2024https://conductscience.org/library/papers/38438374PubMed
1725312543Liposomal carfilzomib nanoparticles effectively target multiple myeloma cells and demonstrate enhanced efficacy in vivo.J Control Release2014https://conductscience.org/library/papers/25312543PubMed
1831689086Overcoming the Reticuloendothelial System Barrier to Drug Delivery with a "Don't-Eat-Us" Strategy.ACS Nano2019https://conductscience.org/library/papers/31689086PubMed
1930538704Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma.Front Immunol2018https://conductscience.org/library/papers/30538704PubMed
2037719368LPS adsorption and inflammation alleviation by polymyxin B-modified liposomes for atherosclerosis treatment.Acta Pharm Sin B2023https://conductscience.org/library/papers/37719368PubMed

See all 36 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42966964Neutrophils: Heterogeneity, Biology, Diseases, and Therapeutic Strategies.MedComm (2020)2026https://conductscience.org/library/papers/42966964PubMed
42322170Engineered Neutrophils in Translational Medicine: Gene Editing, Nanotechnology, and AI-Driven Clinical Breakthroughs.Adv Healthc Mater2026https://conductscience.org/library/papers/42322170PubMed
42288907Liposomal multimodal theranostics for bone disorders: from rational responsive delivery and biomimetic strategies to clinical translation.J Nanobiotechnology2026https://conductscience.org/library/papers/42288907PubMed
41593686Hijacking the helpers: platelet and neutrophil trafficking in AML and therapeutic exploitation.Exp Hematol Oncol2026https://conductscience.org/library/papers/41593686PubMed
41471085Plasma Cell Myeloma: Biochemical Insights into Diagnosis, Treatment, and Smart Nanocarrier-Based Therapeutic Development.Pharmaceutics2025https://conductscience.org/library/papers/41471085PubMed
41328335Neutrophil-based delivery platforms: from natural mechanisms to engineered therapeutics.Theranostics2026https://conductscience.org/library/papers/41328335PubMed
41159240Cancer targeting carfilzomib nanomedicine: a comprehensive review of delivery vehicles and efficacy.Nanomedicine (Lond)2025https://conductscience.org/library/papers/41159240PubMed
39679804Targeted Delivery of c(RGDfk)-Modified Liposomes to Bone Marrow Through In Vivo Hitchhiking Neutrophils for Multiple Myeloma Therapy.Adv Sci (Weinh)2025https://conductscience.org/library/papers/39679804PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39679804

GET https://conductscience.org/api/papers/v1/39679804/references?page=2